Isfahan University of Medical Sciences

Science Communicator Platform

Share By
Unraveling the Molecular Landscape of Pancreatic Cancer: A Systems Biology Approach to Identify Therapeutic Targets Publisher



Ahmadipour E ; Ebrahimi S ; Nasri H ; Amerizadeh F
Authors

Source: Discover Oncology Published:2026


Abstract

Background: Due to late diagnosis and limited treatment options for pancreatic ductal adenocarcinoma (PDAC), identifying novel therapeutic targets is crucial to improving patient outcomes. This study aims to analyze differentially expressed genes (DEGs) in PDAC, identify key hub genes through protein-protein interaction (PPI) network analysis, and propose potential therapeutic targets using drug analysis databases. Methods: Gene expression data were obtained from the Gene Expression Omnibus (GEO) database (GSE101448). Gene ontology (GO) and pathway enrichment analyses were conducted using the Enrichr database. The STRING database was used to construct the PPI network, and hub genes were identified via Cytoscape’s CytoHubba plugin. Promoter analysis of hub genes was conducted using the Tomtom and GOMO tools to identify transcription factors potentially regulating these genes. Cytocluster analysis was performed to identify functional clusters within the protein interaction network. Drug target analysis was conducted through the DrugBank database to identify potential therapeutic compounds for the identified hub genes. Results: Fifteen hub genes were identified, including TP53, FN1, SRC, PTPRC, CD8A, RRM2, KIF20A, AURKA, CCNB1, BUB1, CDCA3, FAM83D, PIMREG, CDCA2, and CKAP2L. Promoter analysis revealed key transcription factors involved in the regulation of these genes, suggesting their role in PDAC progression. Drug analysis revealed several promising therapeutic candidates, such as Nutlin-3, Siremadlin, Dasatinib, Clofarabine, and Ocriplasmin, which target key regulatory pathways involved in tumor progression and cell cycle dysregulation. Conclusion: This study provides valuable insights into the molecular mechanisms underlying pancreatic cancer and identifies potential drug candidates targeting key regulatory genes. Further experimental validation and clinical trials are needed to assess the effectiveness of these identified therapeutic options in improving PDAC treatment outcomes. © The Author(s) 2025.
Related Docs
View other Related Docs
1. Determination of Critical Genes and Key Regulatorys in Colorectal Cancer With Meta‑ and Network Analysis of Microarray Datasets, Advanced Biomedical Research (2025)
2. Clear Cell Renal Cell Carcinoma: A Comprehensive in Silico Study in Searching for Therapeutic Targets, Kidney and Blood Pressure Research (2023)
3. Unveiling Potential Biomarkers for Urinary Tract Infection: An Integrated Bioinformatics Approach, Advanced Biomedical Research (2024)
Experts (# of related papers)
View all Related Experts
Hossein Khanahmad (2)
Alieh Gholaminejad (2)
Other Related Docs
4. In-Silico Identification of Therapeutic Targets in Pancreatic Ductal Adenocarcinoma Using Wgcna and Trader, Scientific Reports (2024)
5. Screening and Identification of Potential Biomarkers for Pancreatic Cancer: An Integrated Bioinformatics Analysis, Pathology Research and Practice (2023)
6. Comprehensive Analysis of Diabetic Nephropathy Expression Profile Based on Weighted Gene Co-Expression Network Analysis Algorithm, BMC Nephrology (2021)
7. Arginine-Proline Metabolism As a Prognostic and Therapeutic Target in Triple-Negative Breast Cancer: An in Silico and Ex Vivo Investigation, Indian Journal of Clinical Biochemistry (2025)
8. Gene Expression Analysis of Colon High-Grade Dysplasia Revealed New Molecular Mechanism of Disease, Gastroenterology and Hepatology from Bed to Bench (2018)
9. The Comparison of Genes and Molecular Pathway Between Newly Diagnosed and Relapsed Acute Lymphocytic Leukemia (All) Patients: A Bioinformatics Analysis, Iranian Journal of Pediatric Hematology and Oncology (2026)
10. Tbx15 and Sdhb Expression Changes in Colorectal Cancer Serve As Potential Prognostic Biomarkers, Experimental and Molecular Pathology (2024)
11. Main Genes Linked to the Immune Microenvironment in High-Grade Serous Ovarian Cancer, Advanced Biomedical Research (2025)
12. Therapeutic Potential of Plk1, Kif4a, Cdca5, Ube2c, Cdt1, Ska3, Aurkb, and Pttg1 Genes in Triple-Negative Breast Cancer: Correlating Their Expression With Sensitivity to Gsk 461364 and Ikk 16 Drugs, Biochemical Genetics (2024)
13. Network Analysis of Common Genes Related to Esophageal, Gastric, and Colon Cancers, Gastroenterology and Hepatology from Bed to Bench (2017)
14. Identification of Hub Genes Associated With Resistance to Prednisolone in Acute Lymphoblastic Leukemia Based on Weighted Gene Co-Expression Network Analysis, Molecular Biotechnology (2023)
15. Analysis of a Four-Component Competing Endogenous Rna Network Reveals Potential Biomarkers in Gastric Cancer: An Integrated Systems Biology and Experimental Investigation, Advanced Biomedical Research (2023)
16. Integrative Bioinformatics and Deep Learning to Identify Common Genetic Pathways in Crohn's Disease and Ischemic Cardiomyopathy, Journal of Genetic Engineering and Biotechnology (2025)
17. Identification of Significant Genes and Pathways Associated With Tenascin-C in Cancer Progression by Bioinformatics Analysis, Advanced Biomedical Research (2022)
18. Central Nodes in Protein Interaction Networks Drive Critical Functions in Transforming Growth Factor Beta-1 Stimulated Kidney Cells, Cell Journal (2016)
19. Dissecting Lncrna-Mrna Regulatory Network in Type 2 Diabetes As the Risk Factor of Pancreatic Cancer, Scientific Reports (2025)
20. Identification of Cancer/Testis Antigens Related to Gastric Cancer Prognosis Based on Co-Expression Network and Integrated Transcriptome Analyses, Advanced Biomedical Research (2023)